Courier Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Courier Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,176	Closed	-$229K	–	306
2022 Q1	$229K	Hold	2,176	–	–	0.02%	273
2021 Q4	$234K	Sell	2,176 -1,253	-37%	-$137K	0.02%	285
2021 Q3	$376K	Hold	3,429	–	–	0.04%	220
2021 Q2	$321K	Hold	3,429	–	–	0.03%	240
2021 Q1	$316K	Buy	+3,429	New	+$289K	0.03%	229

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Courier Capital's HZNP Position: Q2 2022 in Review

Courier Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 2,176 shares — an estimated $229K sold.

Courier Capital first reported a position in HZNP in Q1 2021 and held it in 5 quarters. The position peaked at $376K in Q3 2021. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

Courier Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Courier Capital sold 2,176 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $229K.
Courier Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 5 quarters.
Courier Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $376K in Q3 2021.
616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on Courier Capital's 13F filing for Q2 2022, filed 20 Jul 2022.